ReviewFrontiers in oncology2025

Comparative study of the impact of adjuvant trastuzumab and its biosimilars on cardiac function in HER2-positive early breast cancer patients: a single-center study.

Lok Sze Joyce Au et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.